. 2024 Jan 19;23:18. doi: 10.1186/s12944-024-02010-6

Table 1.

Characteristics of the patients at baseline

variable				Total (6127)	Normal TG (TG < 150) (3167)	High TG (150 ≤ TG < 400)(2960)
Age (yr)				57.72 ± 10.41^#	58.85 ± 10.46	56.88 ± 10.19^a
Female sex (%)				56.6	53.8	60.2
Duration of diabetes (yr)				9.61 ± 7.65	9.74 ± 7.92	9.52 ± 7.39
History of hypertension (%)				43	42	44.4
Weight (kg)				76.00 ± 12.93	74.51 ± 12.73	77.39 ± 12.88^a
Height (cm)				162.42 ± 9.28	162.77 ± 9.30	161.92 ± 9.16^a
BMI (kg/m^2)				28.85 ± 4.66	28.18 ± 4.72	29.54 ± 4.53^a
Waist circumference (cm)				97.83 ± 10.09	96.51 ± 10.17	99.12 ± 9.79^a
Hip circumference (cm)				105.42 ± 8.57	104.40 ± 8.49	106.43 ± 8.61^a
WHR				0.94 ± 0.06	0.93 ± 0.06	0.94 ± 0.06^a
Blood pressure (mm Hg)	Systolic			130.46 ± 17.76	129.75 ± 17.64	131.18 ± 17.82^a
Blood pressure (mm Hg)	Diastolic			78.87 ± 9.33	78.07 ± 9.23	79.63 ± 9.31^a
On anti-hypertensive medications (%)				42.4	41.6	43.7
HbA1c (%)	Mean			7.83 ± 1.70	7.64 ± 1.60	8.00 ± 1.76^a
HbA1c (%)	Median (range)			7.60 (4.0–15.0)	7.40 (4.0–14,7)	7.80 (4.0–15.0)
FBS (mg/ dL)				165.29 ± 60.58	157.58 ± 58.87	171.63 ± 60.51^a
2hPP (mg/ dL)				228.80 ± 90.34	218.45 ± 86.84	237.12 ± 91.83^a
Cholesterol (mg/ dL)	Total			178.57 ± 44.57	162.84 ± 37.64	191.83 ± 44.09^a
	LDL-C			100.64 ± 34.56	93.87 ± 31.08	107.00 ± 36.46^a
	Non-HDL			133.7 ± 42.9	116.28 ± 34.66	148.30 ± 41.73^a
	HDL-C		Total	44.85 ± 11.00	46.56 ± 11.27	43.53 ± 10.38^a
			Women	47.30 ± 11.18	49.44 ± 11.48	45.76 ± 10.48
			Men	41.65 ± 9.89	43.20 ± 10.02	40.16 ± 9.27
TG	Mean (mg/ dL)			173.46 ± 99.37	106.89 ± 25.39	219.02 ± 58.38^a
TG	Median (mg/ dL) (range)			147.00 (34.0–398.0)	108.00 (34.0–149.0)	202.50 (150.0–398.0)
TG/HDL ratio				4.22 ± 3.06	2.44 ± 0.88	5.36 ± 2.11^a
VAI				19.71 ± 3.89	19.22 ± 3.85	20.12 ± 3.86^a
AIP				1.2 ± .6	0.82 ± 0.37	1.61 ± 0.36^a
Creatinine (mg/ dL)				0.99 ± 0.22	0.99 ± 0.22	1.00 ± 0.22
Urea (mg/ dL)				31.78 ± 12.24	31.69 ± 12.47	31.87 ± 11.62
GFR (ml/min/1.73 m²)				83.11 ± 24.61	81.03 ± 24.12	84.70 ± 24.69^a
Medications
OAD (%)				76.49	76.41	76.63
Insulin + OAD (%)				8.74	8.80	8.64
Insulin (%)				14.77	14.79	14.73
Lipid lowering drug		Atorvastatin (%)		72.03	72.30	71.62
Lipid lowering drug		Rosuvastatin (%)		27.97	27.70	28.38

BMI body mass index, HbA1C hemoglobin A1C, FBS fasting blood sugar, 2hPP two-hour postprandial glucose, WHR waist-to-hip ratio, GFR glomerular filtration rate, TG triglyceride, LDL-C low-density lipoprotein cholesterol, HDL-C high-density lipoprotein cholesterol, AIP atherogenic index of plasma, VAI visceral adiposity index, OAD Oral anti-diabetic agents

^#Data are mean ± SD

^aPvalue < 0.05 vs normal TG